Charlotte, North Carolina – Truvada, a popular medication used to treat and even prevent HIV, has been connected with serious complications, including lactic acidosis, kidney failure, and liver and bone problems. These side effects are serious and potentially life-threatening. Recent lawsuits allege that Truvada manufacturer Gilead Sciences knowingly downplayed the potential side effects and, even worse, may have suppressed a safer version of the HIV treatment in order to maximize profits.

Multiple lawsuits have been filed against Gilead Sciences in courts across the country. According to a court filing made on behalf of plaintiffs in California, Gilead Sciences knew as early as 2001 that tenofovir disoproxil fumarate (TDF) was “highly toxic in the doses prescribed and risked permanent and possibly fatal damage to the kidneys and bones.” According to a report from AIDS Healthcare Foundation, a non-profit providing treatment to HIV/AIDS patients worldwide, Gilead Sciences also “deliberately and maliciously suppressed from the market its alternate and newer formulation of the drug … in order to extend the patent life – and sales – of its existing medications that included TDF.”

Gilead has stated that it included warnings about possible harmful side effects of TDF for people who have a history of kidney- or bone-related ailments. The lawsuits claim that the company failed to warn that TDF could cause serious kidney and bone damage for people with no history of kidney or bone conditions. The next time you watch TV, please listen and pay special attention to the long advertisement sponsored by Truvada and decide for yourself. We must exercise caution. (Q Notes Online – Gene Riddle of Riddle & Brantley, a North Carolina law firm that represents injury victims, including those injured by drugs at and the Washington Blade – Lou Chibbaro, Jr. at

Please follow and like us: